Naveed Sattar

机构：Brigham and Women's Hospital, Harvard University, University of Glasgow · ORCID：0000-0002-1604-2593

发表论文 2148 篇 · 总被引 210328 次 · h-index 207

代表论文

• Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes (2025 · New England Journal of Medicine · 被引 137)
• Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial (2025 · JAMA Cardiology · 被引 33)
• Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies (2025 · Diabetologia · 被引 17)
• Tirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial (2025 · Annals of the Rheumatic Diseases · 被引 3)
• Waist, waist-height-ratio vs body mass index and the risks of multiple diseases: a cohort study with replication (2025 · medRxiv · 被引 3)
• Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study (2025 · The Lancet Regional Health - Europe · 被引 2)